ZD6474-a novel inhibitor of VEGFR and EGFR tyrosine kinase activity.

Autor: Ryan, A. J.1, Wedge, S. R.1 steve.wedge@astrazeneca.com
Zdroj: British Journal of Cancer. Jun2005 Supplement, Vol. 92, p6-13. 8p.
Databáze: Academic Search Ultimate